Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction.
about
The role of albumin in human toxicology of cobalt: contribution from a clinical case.Associations among metabolic syndrome, ischemia, inflammatory, oxidatives, and lipids biomarkersEstimation of Ischemia Modified Albumin (IMA) Levels in Patients with Acute Coronary Syndrome.Albumin Cobalt Binding or Ischaemia Modified Albumin: a Test of Great Prognostic Value in Malaria.Development and characterization of a novel fusion protein of a mutated granulocyte colony-stimulating factor and human serum albumin in Pichia pastoris.Redistribution of labile plasma zinc during mild surgical stress in the rat.Role of "Ischemia Modified Albumin" (IMA) in acute coronary syndromesA fast and reproducible method for albumin isolation and depletion from serum and cerebrospinal fluid.Role of "Ischemia modified albumin", a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes.Biomarkers of cardiac disease.Ischemia-modified albumin use as a prognostic factor in coronary bypass surgery.Ischemia modified albumin: A novel marker for acute coronary syndrome.Present and future biochemical markers for detection of acute coronary syndrome.The value of ischemia-modified albumin compared with d-dimer in the diagnosis of pulmonary embolism.Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties.Biomarkers of cardiovascular damage.The clinical assessment of ischaemia modified albumin and troponin I in the early diagnosis of the acute coronary syndromeUtility of admission cardiac troponin and "Ischemia Modified Albumin" measurements for rapid evaluation and rule out of suspected acute myocardial infarction in the emergency department.Evaluation of effects of ischaemia on the albumin cobalt binding (ACB) assay in patients exposed to traumaThe PRIMA study: presentation ischaemia-modified albumin in the emergency department.Comparison of the diagnostic accuracy of ischemia-modified albumin and echocardiography in patients with acute chest pain.Evidence and Cost Effectiveness Requirements for Recommending New BiomarkersDerivation and validation of a sensitive IMA cutpoint to predict cardiac events in patients with chest pain.Biomarkers in Acute Coronary Syndrome.A Microtus fortis protein, serum albumin, is a novel inhibitor of Schistosoma japonicum schistosomula.Current role of ischemia-modified albumin in routine clinical practice.Ischemia modified albumin changes - review and clinical implications.Paraoxonase-1 and ischemia-modified albumin in patients with end-stage renal disease.Neurotoxicity of cobalt.Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality.Albumin in chronic liver disease: structure, functions and therapeutic implications.Ischemia-Modified Albumin as a Marker of Acute Coronary Syndrome: The Case for Revising the Concept of "N-Terminal Modification" to "Fatty Acid Occupation" of Albumin.Evaluation of the Relationship Between Microalbuminuria and Urine Ischemia-Modified Albumin Levels in Patients with Diabetic Nephropathy.Ischemia modified albumin: does it change during pneumoperitoneum in robotic prostatectomies?Diagnostic and prognostic value of Ischemia-modified albumin in patients with Crimean-Congo hemorrhagic fever.Novel application of flow propagation velocity and ischaemia-modified albumin in analysis of postexercise cardiac function in man.Ischaemia-modified albumin: a marker of bacterial infection in hospitalized patients with cirrhosis.Ischemia modified albumin can predict necrosis at incarcerated hernias.Albumin infusion improves renal blood flow autoregulation in patients with acute decompensation of cirrhosis and acute kidney injury.High-performance liquid chromatography (HPLC) determination of inosine, a potential biomarker for initial cardiac ischaemia, using isolated mouse hearts.
P2860
Q30472939-33407A4A-3784-48A9-961E-7E4ED5B732A6Q33736191-C34B056B-3DD8-4667-9FE0-F3239A6A8663Q33774564-DC87B174-3563-4A8E-B82D-46DA5DE4D8DFQ33877922-4B1124E4-1DC0-472F-893C-5607D726E177Q34764811-9E9D75A9-447F-490B-9A52-08C7B06F77E8Q34777927-8BDF1379-EFB3-434B-A9F4-2CA458DBA7ADQ35028692-C7A4B628-1FB3-4275-861B-33D50FE179C0Q35156254-DADF2D7D-17CD-4102-8C72-EDE6A7869158Q35557406-15DF5ED4-448E-45A1-BF75-246E57986D0AQ35938537-1EA4F095-F93B-4591-ACD9-294A77364896Q36099107-7CD6AEDD-F904-4F0B-8AD9-47FEBDA87C37Q36264599-74401D32-85A0-4917-BD4F-354C9A5A1D69Q36624223-F5C064B4-101E-4004-A6E3-54BCE7558ED3Q36727124-75829A56-5232-45E1-9383-129B85F083A2Q36807461-13369DDF-4A34-4F82-9A87-01D5FB9F7DCBQ36836546-A881A7D5-F927-4724-B27C-D57415D1B155Q36924829-18860945-0E27-417A-B495-13B7EDEDD7BDQ36964602-5F160893-605D-4940-995A-CF00E036C4C7Q36964707-B11DE38F-17F8-4B61-A2CB-C5D6388514A4Q36964775-87277E46-223B-4E44-9387-4A17E0457867Q37033121-01F6D308-3B63-413F-A336-1E234BBC45B1Q37155324-669B8E9A-23F1-47B3-8311-83BD0C51C329Q37158173-3B7C6E6A-A675-45E1-BF73-B8C3EDBF3704Q37207294-0489A5D6-0DB2-42C7-955C-EEC79D227E01Q37675099-8AB22040-4E99-4E8D-8104-EEA6FAAE6554Q37793251-442492C1-0BD6-48BA-9594-A03780B27B5AQ37810261-EE0538E2-C31C-4F68-B6A6-6A092D2A7712Q37864183-653EEBC6-A20D-4883-84E6-2C238BDF10D5Q37897790-474E413F-6ECE-4D90-B4BD-D04C8C5C1643Q38471899-1F81B3CF-5AB2-494F-AA02-1A2760D843ADQ38595462-8F767994-8237-4F57-8990-C98A48BA145BQ39207507-39938082-6D9A-4336-96E9-131DAC4366D9Q39328364-CB1C5131-CE07-4426-849D-F7C99DD104D2Q39620019-35766FAC-650E-4C64-8D03-6F49CF9D51C3Q40258997-B2BC9358-54A3-4397-9D90-6250BFE86D54Q40356338-1402A884-9DFB-4581-9ECE-BA9570253020Q41260673-214F14C4-9505-4FEC-8D9C-3C460CF83058Q41988208-19EABF0E-3BDA-482C-8327-8D9BB0015869Q44470119-C7FA0AE0-921F-411C-A79C-2F4F80B37D99Q44923209-5201C773-B89C-4F8E-BAC7-85E38ACF7A91
P2860
Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Evaluation of human serum albu ...... mia and myocardial infarction.
@en
Evaluation of human serum albu ...... mia and myocardial infarction.
@nl
type
label
Evaluation of human serum albu ...... mia and myocardial infarction.
@en
Evaluation of human serum albu ...... mia and myocardial infarction.
@nl
prefLabel
Evaluation of human serum albu ...... mia and myocardial infarction.
@en
Evaluation of human serum albu ...... mia and myocardial infarction.
@nl
P2093
P356
P1433
P1476
Evaluation of human serum albu ...... mia and myocardial infarction.
@en
P2093
Anna M Ortega-Lopez
Carlos N Rios
Cheryl E Sugiyama
Chung-Eun Ha
Ernest M Lai
Hiroko Shinoda
Jinsheng Yang
Nadhipuram V Bhagavan
Patricia A Rios
Stacey A A Honda
P304
P356
10.1373/49.4.581
P407
P577
2003-04-01T00:00:00Z